ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2015
Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?
Katelijne van de Vooren et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it